M. Gholam-Rezaee

Discipline

Psychologie (12) Education (1)

Type de document

Articles (29) Autres (1)

Co-auteur

Date

Source

Mot-clé

adulte (19) Human beings (19) adulte (19) Treatment (16) Patients (16) Patients (16) association (15) Social groups (15) Older people (15) risque (13) âge (13) Risk (13) Population (13) Age (13) Age (13) Population (13) cohorte (13) Depression, Mental (11) puits (10) Psychotropic drugs (10) Months (10) Manufacturers' agents (9) Commission merchants (9) Body mass index (9) poids (8) santé (8) effet (8) Development (8) Ci (Chinese poetry) (8) Psychiatry (8)

Documents écrit par M. Gholam-Rezaee (29) | parle de M. Gholam-Rezaee (0)

CYP2C19 expression modulates affective functioning and hippocampal subiculum volume-a large single-center community-dwelling cohort study.
C. Grosu et al. (5 août 2022)
Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
C. Dubath et al. (7 oct. 2021)
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
C. Dubath et al. (26 juin 2021)
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants.
S.H. Kanders et al.
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication.
L. Alameda et al. (2020)
Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients.
A. Delacrétaz et al. (26 déc. 2019)
Mental disorders, attrition at follow-up, and questionnaire non-completion in epidemiologic research. Illustrations from the CoLaus|PsyCoLaus study.
M. Dupuis et al.
Differences between unipolar mania and bipolar-I disorder: Evidence from nine epidemiological studies.
J. Angst et al.
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset Hypercholesterolemia.
A. Delacrétaz et al. (9 avr. 2019)
Associations of Personality Traits With Chronic Low-Grade Inflammation in a Swiss Community Sample.
E.N. Wagner et al. (2019)
Psychosocial Stress Over the Lifespan, Psychological Factors, and Cardiometabolic Risk in the Community.
S.Z. Gebreab et al.
Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study.
J. Glaus et al.
The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: Results from a large longitudinal population-based study.
J. Glaus et al.
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
P. Conus et al. (15 févr. 2018)
Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.
A. Delacrétaz et al. (2018)
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs.
A. Delacrétaz et al.
Partially distinct combinations of psychological, metabolic and inflammatory risk factors are prospectively associated with the onset of the subtypes of Major Depressive Disorder in midlife.
D.A. Rudaz et al.
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.
A. Delacrétaz et al. (10 sept. 2017)
The Lausanne-Geneva cohort study of offspring of parents with mood disorders: methodology, findings, current sample characteristics, and perspectives.
C.L. Vandeleur et al.
Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population.
A.M. Lasserre et al.
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
F. Vandenberghe et al.
Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression.
L. Quteineh et al. (1 juil. 2016)
The specificity of the familial aggregation of early-onset bipolar disorder: A controlled 10-year follow-up study of offspring of parents with mood disorders.
M. Preisig et al. (2016)
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.
A. Delacrétaz et al. (2015)
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
L. Quteineh et al. (2015)

next